The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Mark J. McKeage

The University of Auckland

Auckland

New Zealand

[email]@auckland.ac.nz

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • The University of Auckland, Auckland, New Zealand. 2012
  • Cancer Clinical Pharmacology Research Group, Auckland Cancer Society Research Centre, School of Medical Sciences, Faculty of Medical and Health Sciences. 2009 - 2012
  • Department of Pharmacology and Clinical Pharmacology, The University of Auckland, Grafton, Auckland, New Zealand. 1999 - 2010
  • The University of Auckland, School of Medical Sciences, Department of Pharmacology and Clinical Pharmacology, Private Bag 92019, New Zealand. 2008

References

  1. PR-104 a bioreductive pre-prodrug combined with gemcitabine or docetaxel in a phase Ib study of patients with advanced solid tumours. McKeage, M.J., Jameson, M.B., Ramanathan, R.K., Rajendran, J., Gu, Y., Wilson, W.R., Melink, T.J., Tchekmedyian, N.S. BMC. Cancer (2012) [Pubmed]
  2. Mass balance, excretion and metabolism of [(14)C] ASA404 in cancer patients in a phase I trial. McKeage, M.J., Fong, P.C., Hong, X., Flarakos, J., Mangold, J., Du, Y., Tanaka, C., Schran, H. Cancer Chemother. Pharmacol. (2012) [Pubmed]
  3. Oxaliplatin Transport Mediated by Organic Cation/Carnitine Transporters OCTN1 and OCTN2 in Overexpressing Human Embryonic Kidney 293 Cells and Rat Dorsal Root Ganglion Neurons. Jong, N.N., Nakanishi, T., Liu, J.J., Tamai, I., McKeage, M.J. J. Pharmacol. Exp. Ther. (2011) [Pubmed]
  4. A phase I trial of PR-104, a pre-prodrug of the bioreductive prodrug PR-104A, given weekly to solid tumour patients. McKeage, M.J., Gu, Y., Wilson, W.R., Hill, A., Amies, K., Melink, T.J., Jameson, M.B. BMC. Cancer (2011) [Pubmed]
  5. Disrupting established tumor blood vessels: an emerging therapeutic strategy for cancer. McKeage, M.J., Baguley, B.C. Cancer (2010) [Pubmed]
  6. Phase II study of ASA404 (vadimezan, 5,6-dimethylxanthenone-4-acetic acid/DMXAA) 1800mg/m(2) combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancer. McKeage, M.J., Reck, M., Jameson, M.B., Rosenthal, M.A., Gibbs, D., Mainwaring, P.N., Freitag, L., Sullivan, R., Von Pawel, J. Lung. Cancer (2009) [Pubmed]
  7. The potential of DMXAA (ASA404) in combination with docetaxel in advanced prostate cancer. McKeage, M.J. Expert. Opin. Investig. Drugs (2008) [Pubmed]
  8. Satraplatin in hormone-refractory prostate cancer and other tumour types: pharmacological properties and clinical evaluation. McKeage, M.J. Drugs (2007) [Pubmed]
  9. 5,6-Dimethylxanthenone-4-acetic acid in the treatment of refractory tumors: a phase I safety study of a vascular disrupting agent. McKeage, M.J., Fong, P., Jeffery, M., Baguley, B.C., Kestell, P., Ravic, M., Jameson, M.B. Clin. Cancer Res. (2006) [Pubmed]
  10. New-generation platinum drugs in the treatment of cisplatin-resistant cancers. McKeage, M.J. Expert. Opin. Investig. Drugs (2005) [Pubmed]
  11. Gold opens mitochondrial pathways to apoptosis. McKeage, M.J. Br. J. Pharmacol. (2002) [Pubmed]
  12. Lobaplatin: a new antitumour platinum drug. McKeage, M.J. Expert. Opin. Investig. Drugs (2001) [Pubmed]
  13. Role of lipophilicity in determining cellular uptake and antitumour activity of gold phosphine complexes. McKeage, M.J., Berners-Price, S.J., Galettis, P., Bowen, R.J., Brouwer, W., Ding, L., Zhuang, L., Baguley, B.C. Cancer Chemother. Pharmacol. (2000) [Pubmed]
  14. Neuroprotective interactions in rats between paclitaxel and cisplatin. McKeage, M.J., Haddad, G.G., Ding, L., Galettis, P., Screnci, D., Zhuang, L., Baguley, B.C. Oncol. Res. (1999) [Pubmed]
 
WikiGenes - Universities